Statistics for A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC

Total visits

views
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC 2

Total visits per month

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 2
June 2025 0
July 2025 0

File Visits

views
Hahn2025Phase-CCBY.pdf 1

Top country views

views
United States 2

Top city views

views
Franklin 2